SELECT MED HLDGS CORP's ticker is SEM and the CUSIP is 81619Q105. A total of 161 filers reported holding SELECT MED HLDGS CORP in Q4 2015. The put-call ratio across all filers is 236.77 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,908,148 | -55.0% | 115,083 | -43.3% | 0.00% | -50.0% |
| Q2 2023 | $6,469,587 | +0.7% | 203,063 | -18.3% | 0.01% | 0.0% |
| Q1 2023 | $6,425,147 | +0.6% | 248,555 | -3.4% | 0.01% | -11.1% |
| Q4 2022 | $6,385,829 | -34.3% | 257,182 | -41.6% | 0.01% | -35.7% |
| Q3 2022 | $9,726,851 | +29.8% | 440,129 | +38.7% | 0.01% | -26.3% |
| Q2 2022 | $7,493,000 | -50.2% | 317,236 | -49.4% | 0.02% | -38.7% |
| Q1 2022 | $15,040,000 | -28.4% | 626,940 | -12.3% | 0.03% | -22.5% |
| Q4 2021 | $21,013,000 | -12.7% | 714,702 | +7.4% | 0.04% | -16.7% |
| Q3 2021 | $24,072,000 | +40.0% | 665,529 | +63.5% | 0.05% | +45.5% |
| Q2 2021 | $17,200,000 | +15.6% | 407,015 | -6.7% | 0.03% | +10.0% |
| Q1 2021 | $14,876,000 | +8.0% | 436,259 | -12.4% | 0.03% | +7.1% |
| Q4 2020 | $13,775,000 | +10.7% | 498,021 | -16.7% | 0.03% | 0.0% |
| Q3 2020 | $12,445,000 | -16.1% | 597,738 | -40.7% | 0.03% | -20.0% |
| Q2 2020 | $14,837,000 | -18.7% | 1,007,209 | -17.2% | 0.04% | -28.6% |
| Q1 2020 | $18,240,000 | -28.9% | 1,216,002 | +10.6% | 0.05% | -7.5% |
| Q4 2019 | $25,664,000 | +18.4% | 1,099,553 | -15.9% | 0.05% | +12.8% |
| Q3 2019 | $21,671,000 | +43.7% | 1,307,844 | +37.7% | 0.05% | +46.9% |
| Q2 2019 | $15,076,000 | -37.4% | 949,934 | -44.4% | 0.03% | -40.7% |
| Q1 2019 | $24,065,000 | -20.3% | 1,707,967 | -13.1% | 0.05% | -27.0% |
| Q4 2018 | $30,184,000 | +6.6% | 1,966,382 | +27.7% | 0.07% | +27.6% |
| Q3 2018 | $28,324,000 | -21.0% | 1,539,377 | -22.1% | 0.06% | -23.7% |
| Q2 2018 | $35,870,000 | +4.9% | 1,976,306 | -0.3% | 0.08% | +4.1% |
| Q1 2018 | $34,186,000 | +10.9% | 1,981,771 | +13.5% | 0.07% | +14.1% |
| Q4 2017 | $30,831,000 | -8.3% | 1,746,773 | -0.2% | 0.06% | -11.1% |
| Q3 2017 | $33,616,000 | +18.3% | 1,750,796 | -5.4% | 0.07% | +12.5% |
| Q2 2017 | $28,407,000 | +43.2% | 1,850,668 | +24.5% | 0.06% | +42.2% |
| Q1 2017 | $19,837,000 | +0.9% | 1,485,947 | +0.2% | 0.04% | -4.3% |
| Q4 2016 | $19,651,000 | -14.2% | 1,483,059 | -12.6% | 0.05% | +9.3% |
| Q3 2016 | $22,898,000 | +16.3% | 1,696,100 | -6.4% | 0.04% | -10.4% |
| Q2 2016 | $19,697,000 | +19.0% | 1,812,081 | +29.2% | 0.05% | +17.1% |
| Q1 2016 | $16,558,000 | +10.2% | 1,402,009 | +11.2% | 0.04% | +10.8% |
| Q4 2015 | $15,022,000 | -0.5% | 1,261,334 | -9.9% | 0.04% | -2.6% |
| Q3 2015 | $15,102,000 | -31.3% | 1,399,659 | +3.1% | 0.04% | -24.0% |
| Q2 2015 | $21,998,000 | +11.8% | 1,357,935 | +2.3% | 0.05% | +13.6% |
| Q1 2015 | $19,684,000 | +50.1% | 1,327,328 | +45.7% | 0.04% | +51.7% |
| Q4 2014 | $13,114,000 | +492.1% | 910,729 | +394.5% | 0.03% | +480.0% |
| Q3 2014 | $2,215,000 | +324.3% | 184,161 | +450.6% | 0.01% | +400.0% |
| Q2 2014 | $522,000 | +78.2% | 33,448 | +42.3% | 0.00% | 0.0% |
| Q1 2014 | $293,000 | +7.3% | 23,500 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $273,000 | +43.7% | 23,500 | 0.0% | 0.00% | – |
| Q3 2013 | $190,000 | -1.6% | 23,500 | 0.0% | 0.00% | -100.0% |
| Q2 2013 | $193,000 | – | 23,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Standard LLC | 213,703 | $5,524,223 | 5.60% |
| Camber Capital Management LP | 4,800,000 | $124,080 | 3.82% |
| Hood River Capital Management LLC | 2,693,137 | $69,618,000 | 2.25% |
| Smith, Graham & Co., Investment Advisors, LP | 434,878 | $11,241,596 | 1.37% |
| Sivik Global Healthcare LLC | 107,838 | $2,788 | 1.20% |
| Capital Impact Advisors, LLC | 33,173 | $857,522 | 1.05% |
| DENALI ADVISORS LLC | 85,772 | $2,217,206 | 0.92% |
| CLOUGH CAPITAL PARTNERS L P | 297,500 | $7,690,375 | 0.83% |
| Huber Capital Management LLC | 127,603 | $3,298,537 | 0.82% |
| Nebula Research & Development LLC | 12,442 | $321,626 | 0.57% |